BNP Paribas Financial Markets Invests $534,000 in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
BNP Paribas Financial Markets purchased a new position in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund purchased 176,292 shares of the company’s stock, valued at approximately $534,000. Several other hedge funds have also recently added to or reduced their stakes in the business. Voya […]
BNP Paribas Financial Markets purchased a new position in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund purchased 176,292 shares of the company’s stock, valued at approximately $534,000. Several other hedge funds have also recently added to or reduced their stakes in the business. Voya […]
